LT - Farmacinė kompozicija, skirta vėžio metastazės slopinimui, apimanti, kaip veiklųjį ingredientą, antikūną, kuris specifiškai rišasi prie epidermio augimo faktoriaus receptoriaus
EN - PHARMACEUTICAL COMPOSITION FOR INHIBITING METASTASIS OF CANCER, COMPRISING, AS ACTIVE INGREDIENT, ANTIBODY THAT SPECIFICALLY BINDS TO EPIDERMAL GROWTH FACTOR RECEPTOR
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 16/28 |
(2006.01) |
|
|
A61K 39/395 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3449939 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
16900546.9 |
|
Date of filing the European patent application |
2016-04-27 |
| (97) |
Date of publication of the European application |
2019-03-06 |
| (45) |
Date of publication and mention of the grant of the patent |
2022-03-30
|
| (46) |
Date of publication of the claims translation |
2022-05-25
|
PCT application
| (86) |
Number |
PCT/KR2016/004418 |
|
Date |
2016-04-27 |
PCT application publication
| (87) |
Number |
WO 2017/188472 |
|
Date |
2017-11-02 |
Inventors
| (72) |
WON, Jong-Hwa , KR
LIM, Yangmi , KR
HUR, Min-Kyu , KR
|
Grantee
| (73) |
Green Cross Corporation ,
107 Ihyeon-ro 30beon-gil
Giheung-gu, Yongin-si, Gyeonggi-do 16924,
KR
Mogam Institute for Biomedical Research ,
93, Ihyeon-ro 30beon-gil
Giheung-gu Yongin-si, Gyeonggi-do 16924,
KR
|
Attorney or representative
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Farmacinė kompozicija, skirta vėžio metastazės slopinimui, apimanti, kaip veiklųjį ingredientą, antikūną, kuris specifiškai rišasi prie epidermio augimo faktoriaus receptoriaus |
| |
PHARMACEUTICAL COMPOSITION FOR INHIBITING METASTASIS OF CANCER, COMPRISING, AS ACTIVE INGREDIENT, ANTIBODY THAT SPECIFICALLY BINDS TO EPIDERMAL GROWTH FACTOR RECEPTOR |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-03-07 |
8 |
185.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2024-04-27 |
